<DOC>
	<DOCNO>NCT03043846</DOCNO>
	<brief_summary>This interventional , pragmatic , prospective , randomize ( cluster ) study evaluate potential benefit Treat Target approach comparison routine treatment ( i.e . usual care ) patient axial spondyloarthritis .</brief_summary>
	<brief_title>Treat Target Trial Axial Spondylo Arthritis : The TICOSPA ( Tight Control Spondyloarthritis )</brief_title>
	<detailed_description>This study reflect usual care either accordance treat rheumatologist ( arm : usual care ) accordance international scientific recommendation ( arm : T2T ) The tight control mean soon treatment initiated patient , time permit evaluate potential efficacy/safety determine . In term safety , time frame short base occurrence adverse event . In term efficacy usually recommend evaluate NSAIDs 2 4 week treatment intake TNF blocker 12 16 week . The Treat Target mean priori decision target reach initiate treatment importantly priori decision intensify treatment case target achieve . There 2 arm study ( tight control treat target arm usual care arm ) . 160 patient ( 80 patient per arm ) include one year 18 center ( 10 France , 4 Belgium 4 Netherlands ) . Patients follow 1 year .</detailed_description>
	<mesh_term>Spondylarthritis</mesh_term>
	<criteria>Adults ( 18 65 year old ) With diagnosis axial spondyloarthritis accord axial ASAS criterion AND opinion treat rheumatologist . Active disease define ASDAS â‰¥ 2.1 Predominant axial disease meaning : Patients nonspinal rheumatological symptom and/or extrarheumatological manifestation require baseline initiation specific treatment exclude . Patients past history and/or current well controlled nonspinal rheumatological extrarheumatological feature eligible study . Nonoptimally treated NSAIDs ( i.e . receive least 2 NSAIDS , daily least 2 week full dose ) . Annex III summarize list commonly use NSAIDs definition `` full '' use . With available pelvic Xrays , B27 MRI sacroiliac joint ( perform time since symptom onset ) With contraindication use NSAID With intake apremilast previous 3 month Able understand objective study fill questionnaire Written inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Treat Target approach</keyword>
</DOC>